Trial Profile
Ranolazine Effects on Ischemic Mitral Regurgitation Severity in Patients With Cardiac Resynchronization Therapy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2013
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Mitral valve disorders
- Focus Therapeutic Use
- Acronyms REIN-MR
- 30 Nov 2013 New trial record